These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26530056)

  • 1. Targeting Dopaminergic System for Treating Nicotine Dependence.
    Abuhamdah S; Khalil A; Sari Y
    Cent Nerv Syst Agents Med Chem; 2016; 16(2):137-42. PubMed ID: 26530056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibition for tobacco pharmacotherapy.
    George TP; Weinberger AH
    Clin Pharmacol Ther; 2008 Apr; 83(4):619-21. PubMed ID: 18091758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
    Chiamulera C; Marzo CM; Balfour DJK
    Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
    D'Souza MS; Markou A
    Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double target concept for smoking cessation.
    Wu J
    Acta Pharmacol Sin; 2010 Sep; 31(9):1015-8. PubMed ID: 20711220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE; Behm FM; Ramsey C; Ritchie JC
    Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioid system: a promising target for future smoking cessation medications.
    Norman H; D'Souza MS
    Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation pharmacotherapy.
    Frishman WH
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):287-308. PubMed ID: 19491139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase and tobacco dependence.
    Lewis A; Miller JH; Lea RA
    Neurotoxicology; 2007 Jan; 28(1):182-95. PubMed ID: 16859748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacological treatments for nicotine dependence.
    George TP; O'Malley SS
    Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
    Liechti ME; Markou A
    CNS Drugs; 2008; 22(9):705-24. PubMed ID: 18698872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
    Frishman WH
    Prev Cardiol; 2007; 10(2 Suppl 1):10-22. PubMed ID: 17396063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor-based therapeutics and candidates for smoking cessation.
    Dwoskin LP; Smith AM; Wooters TE; Zhang Z; Crooks PA; Bardo MT
    Biochem Pharmacol; 2009 Oct; 78(7):732-43. PubMed ID: 19523455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
    Smith LC; George O
    Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
    Desai RI; Bergman J
    Neuropsychopharmacology; 2016 Jan; 41(1):377-8. PubMed ID: 26657956
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.
    Hong SW; Teesdale-Spittle P; Page R; Truman P
    Neurotoxicology; 2022 Dec; 93():163-172. PubMed ID: 36155069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of tobacco dependence: a commentary.
    Balfour DJ
    Respiration; 2002; 69(1):7-11. PubMed ID: 11844955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved treatment of nicotine addiction and emerging pulmonary drug delivery.
    Islam N; Rahman S
    Drug Discov Ther; 2012 Jun; 6(3):123-32. PubMed ID: 22890202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.